Category Venues

Several WIPO Committee Reports Stamped by General Assembly; Dissent Persists

Every year at this time, various World Intellectual Property Organization committees give a report to the organisation’s General Assembly on their past year’s activities and recommendations for decisions to be taken, including work they will be undertaking during the next year. At this week’s Assembly, reports were noted from committees on patents, trademarks, WIPO standards, and enforcement.

Lisbon GI Revision A Hot Topic As Members Prepare For Treaty Talks

A proposed amendment to the Lisbon Agreement protecting appellations of origin at the World Intellectual Property Organization is the object of heated discussions between proponents of geographical indications and countries favouring other systems such as trademarks to protect such intellectual property titles. A side event to this week’s WIPO General Assemblies gathered GI proponents to ponder the future of the agreement.

Strengthening WIPO’s Governance For The Next 50 Years: A Time For Action

In 2017, the World Intellectual Property Organization (WIPO) will mark its 50th anniversary. In the lead up to that milestone, the next three years provide a vital opportunity for Member States to update and strengthen WIPO’s governance, both to address current problems and to better equip the organisation for addressing challenges that may arise in the next 50 years, writes Carolyn Deere Birkbeck.

WIPO General Assembly Highlights Positions On Key IP Policy Issues

In the opening days of this week’s annual World Intellectual Property Organization General Assembly, member governments showed a diversity of views on issues such as negotiations for possible treaties on broadcasters’ rights, design law, copyright exceptions for libraries, and protection of traditional knowledge. But one of the biggest gaps is over the future of the WIPO Development Agenda, with some countries suggesting a new course for this agenda, and proponents deeply concerned about a loss of momentum.

Gilead Monopoly Prevails Over Non-Discriminatory Access As Debated Hepatitis C Deal Sets Off

Gilead on 15 September struck voluntary licence deals with seven India-based generic manufacturers to expand access to its hepatitis C innovative drugs in developing countries. With a limited territory covered, this, yet deserving, pact raises doubts about the coherence of Indian counterparts at a time when there are no relevant patents in India, several pre-grant oppositions have been filed and unrestrained competition by compulsory licences could have been pursued, writes Daniele Dionisio.